Dichotomous role of TGF-β controls inducible regulatory T-cell fate in allergic airway disease through Smad3 and TGF-β–activated kinase 1
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 145 (3) , 933-946.e4
Abstract
No abstract availableKeywords
Funding Information
- National Jewish Health
- National Institutes of Health
This publication has 45 references indexed in Scilit:
- Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathwaysJournal of Allergy and Clinical Immunology, 2017
- An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cellsNature Medicine, 2016
- Development and Maintenance of Regulatory T cellsImmunity, 2013
- CD8 Regulates T Regulatory Cell Production of IL-6 and Maintains Their Suppressive Phenotype in Allergic Lung DiseaseThe Journal of Immunology, 2011
- Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivoNature Immunology, 2009
- Plasticity of Regulatory T Cells: Subversion of Suppressive Function and Conversion to Enhancement of Lung Allergic ResponsesThe Journal of Immunology, 2008
- Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expressionNature, 2007
- Adaptive Islet-Specific Regulatory CD4 T Cells Control Autoimmune Diabetes and Mediate the Disappearance of Pathogenic Th1 Cells In VivoThe Journal of Immunology, 2006
- Inducing and expanding regulatory T cell populations by foreign antigenNature Immunology, 2005
- Oral tolerance in the absence of naturally occurring TregsJournal of Clinical Investigation, 2005